health pharma news today obesity drugs glp-1 today What is the pipeline for future medications for obesity? GLP-1 Drug Market: the rapid
Description
What if a decades-old diabetes drug could reshape how we treat multiple sclerosis, especially for women
Engineering new peptides with desired selectivity profiles requires time-consuming and expensive cycles of design-make-test-analyse (DMTA) work
Due to body habitus, neither magnetic resonance imaging (MRI) nor lumbar puncture was possible to obtain
M., Martinou, E
A, amyloid-beta
Therefore, conducting studies under thermoneutral conditions may provide a way to evaluate treatment effects in CNS GIPR KO mice independently of body weight defence mechanisms and temperature-associated thermogenesis
